Elekta (OTCMKTS:EKTAY) Shares Gap Down – What’s Next?

Elekta AB (OTCMKTS:EKTAYGet Free Report)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $5.24, but opened at $4.88. Elekta shares last traded at $4.88, with a volume of 5,426 shares.

Analyst Upgrades and Downgrades

Separately, Zacks Research downgraded shares of Elekta from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 2nd. Two research analysts have rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

Get Our Latest Report on EKTAY

Elekta Price Performance

The company has a market cap of $1.80 billion, a price-to-earnings ratio of -30.44 and a beta of 1.01. The company has a quick ratio of 0.68, a current ratio of 0.87 and a debt-to-equity ratio of 0.47. The company’s fifty day moving average price is $5.61 and its two-hundred day moving average price is $5.97.

Elekta (OTCMKTS:EKTAYGet Free Report) last issued its quarterly earnings data on Thursday, May 28th. The company reported $0.06 EPS for the quarter. The business had revenue of $521.00 million for the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%. On average, equities research analysts forecast that Elekta AB will post 0.43 EPS for the current fiscal year.

Elekta Company Profile

(Get Free Report)

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.

Read More

Receive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.